Title
Date Published
The Use of Antifibrinolytic Agents in Total Hip Arthroplasty A Meta-analysis.
September 1, 2006
Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery.
August 1, 2006
Perioperative management of coagulation
August 1, 2006
Recombinant factor VIIa and the surgical patient.
August 1, 2006
Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy–a porcine model.
August 1, 2006
The Clinical and Laboratory Response to Recombinant Factor VIIa in Trauma and Surgical Patients with Acquired Coagulopathy.
July 31, 2006
Laser therapy and surgical treatment in transfusion-dependent patients with upper-gastrointestinal vascular ectasia.
July 29, 2006
Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation.
July 12, 2006
Reversal of low-molecular-weight heparin-induced bleeding in patients with pre-existing hypercoagulable states with human recombinant activated factor VII concentrate.
July 5, 2006
Effects of Cardiac Surgery on Hemostasis.
July 1, 2006
Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
June 30, 2006
The Risk Associated with Aprotinin in Cardiac Surgery
June 30, 2006
Recombinant Factor VII (Activated) for Haemorrhagic Complications of Severe Sepsis Treated with Recombinant Protein C (Activated).
June 30, 2006
Could discontinuation of aspirin therapy be a trigger for stroke?
June 30, 2006
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.
June 20, 2006
Intraoperative use of recombinant activated factor VII (rFVIIa).
June 1, 2006
Use of recombinant activated factor VII to control bleeding in a young child with qualitative platelet disorder: a case report.
June 1, 2006
Pharmacological approaches to reducing blood loss and transfusions in the surgical patient.
June 1, 2006
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.
June 1, 2006
A case of Glanzmann’s thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug.
June 1, 2006